Showing results (41-50 of 90) with videos related to
Sort By:
Pageof 9
Therapie|May 1, 1989
[Drug-induced respiratory complications. Study of 27 cases]P Foucher, M Perrichon, F Massin, et al.International Journal of Antimicrobial Agents|May 5, 2000
The French antibiotic resistance monitoring programsJ L Martel, F Tardy, A Brisabois, et al.Annales Francaises D'Anesthesie Et De Reanimation|January 5, 2002
[Acute severe pain in emergencies. The key for efficient analgesia]K Milojevic, J P Cantineau, L Simon, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2011
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapyB Coudert, T Ciuleanu, K Park, et al.Annales De Cardiologie Et D'Angeiologie|January 1, 1987
[Tricuspid endocarditis with right-left auricular shunt through a patent foramen ovale]P Morelon, J C Eicher, P Chavanet, et al.Bulletin Du Cancer|January 22, 1998
[Clinical value of the estimation of growth kinetics of primary ovarian cancer recurrences by CA125 doubling time]J M Riedinger, B Coudert, I Barillot, et al.British Journal of Cancer|July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalS Ladoire, L Arnould, G Mignot, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Age and prognosis of non-small cell lung cancer. Usefulness of a relative survival modelP Foucher, B Coudert, P Arveux, et al.Revue De Pneumologie Clinique|July 6, 2000
[Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma]P Rebattu, B Coudert, M Schneider, et al.Clinical Cardiology|October 2, 1998
Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiographyY Cottin, C Touzery, F Dalloz, et al.Pageof 9